GLP-1s as a chronic care lever: Why payers are moving beyond restriction
This webinar is on-demand and can be viewed at your convenience.
GLP-1 utilization is climbing and so are the costs. For payers and employers, the instinct is to restrict access, layer on prior authorizations and focus narrowly on pharmacy spend.
The problem with that approach is it often backfires. Members discontinue therapy without support, regain weight, cycle back into higher-acuity care settings and drive up total cost of care. Restrictive benefit designs may reduce short-term pharmacy costs, but they can create long-term financial and clinical liabilities that are far more expensive to manage.
There is a better path. This webinar explores how forward-looking organizations are redesigning GLP-1 benefits around structured support, sustained engagement and behavior change, turning a reactive pharmacy expense into a proactive strategy for chronic disease management and meaningful ROI.
Key learnings:
The problem with that approach is it often backfires. Members discontinue therapy without support, regain weight, cycle back into higher-acuity care settings and drive up total cost of care. Restrictive benefit designs may reduce short-term pharmacy costs, but they can create long-term financial and clinical liabilities that are far more expensive to manage.
There is a better path. This webinar explores how forward-looking organizations are redesigning GLP-1 benefits around structured support, sustained engagement and behavior change, turning a reactive pharmacy expense into a proactive strategy for chronic disease management and meaningful ROI.
Key learnings:
-
Why restriction-first approaches to GLP-1s can increase total cost of care over time
-
How integrating behavior change with medication support improves adherence, outcomes and ROI
-
What a total-cost-of-care measurement framework reveals about the real value of GLP-1 programs
-
How reducing discontinuation and weight regain protects both member health and financial performance
Presenter:
